Why AbbVie Could Join the M&A Mania Soon Post author:Sam Post published:January 30, 2018 Post category:BioPharma The company expects to only pay a tax rate of 9 percent this year, which will free up a lot of cash. Source: BioSpace You Might Also Like Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies December 13, 2017 Check-Cap Reports First Quarter 2017 Financial Results May 8, 2017 Innovia To Report Fourth Quarter And Full Year 2016 Financial Results On February 9, 2017 At 5:00 P.M. EST February 2, 2017
Innovia To Report Fourth Quarter And Full Year 2016 Financial Results On February 9, 2017 At 5:00 P.M. EST February 2, 2017